ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

ClinicalTrials.gov ID: NCT05773274

Public ClinicalTrials.gov record NCT05773274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus or Sunitinib or Cabozantinib in Metastatic/Unresectable Gastroenteropancreatic Neuroendocrine Tumours

Study identification

NCT ID
NCT05773274
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
100 participants

Conditions and interventions

Interventions

  • Biospecimen Collection Procedure
  • Cabozantinib Drug
  • Computed Tomography Procedure
  • Everolimus Drug
  • Lutetium Lu 177 Dotatate Drug
  • Magnetic Resonance Imaging Procedure
  • Quality-of-Life Assessment Other
  • Questionnaire Administration Other
  • Sunitinib Drug

Procedure · Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2024
Primary completion
Apr 29, 2029
Completion
Apr 29, 2029
Last update posted
May 5, 2026

2024 – 2029

United States locations

U.S. sites
30
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 Suspended
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 Recruiting
Banner University Medical Center - Tucson Tucson Arizona 85719 Recruiting
University of Arizona Cancer Center-North Campus Tucson Arizona 85719 Recruiting
UCHealth University of Colorado Hospital Aurora Colorado 80045 Recruiting
UM Sylvester Comprehensive Cancer Center at Aventura Aventura Florida 33180 Recruiting
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146 Recruiting
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442 Recruiting
Mayo Clinic in Florida Jacksonville Florida 32224-9980 Suspended
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 Recruiting
UM Sylvester Comprehensive Cancer Center at Kendall Miami Florida 33176 Recruiting
UM Sylvester Comprehensive Cancer Center at Plantation Plantation Florida 33324 Recruiting
Northwestern University Chicago Illinois 60611 Recruiting
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 Recruiting
Northwestern Medicine Cancer Center Kishwaukee DeKalb Illinois 60115 Recruiting
Northwestern Medicine Cancer Center Delnor Geneva Illinois 60134 Recruiting
UC Comprehensive Cancer Center at Silver Cross New Lenox Illinois 60451 Recruiting
University of Chicago Medicine-Orland Park Orland Park Illinois 60462 Recruiting
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555 Recruiting
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny Iowa 50023 Recruiting
Iowa Methodist Medical Center Des Moines Iowa 50309 Recruiting
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines Iowa 50309 Recruiting
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee Iowa 50263 Recruiting
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 Suspended
Henry Ford Hospital Detroit Michigan 48202 Recruiting
Mayo Clinic in Rochester Rochester Minnesota 55905 Recruiting
University of New Mexico Cancer Center Albuquerque New Mexico 87106 Recruiting
University of Rochester Rochester New York 14642 Recruiting
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 Recruiting
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05773274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05773274 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →